Jakap Koo - Director at Apimeds Pharmaceuticals US, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
APUS on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jakap Koo since 03 Mar 2025

Holdings reported by Jakap Koo for Apimeds Pharmaceuticals US, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.01 per share 643,885 12 May 2025 Direct
Stock Option (right to buy) 10,000 11 Nov 2025 Direct Common Stock, par value $0.01 per share

Transactions reported by Jakap Koo for Apimeds Pharmaceuticals US, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.